Cited by

• Blood eosinophils, fractional exhaled nitric oxide and the risk of asthma attacks in randomised controlled trials: protocol for a systemic review and control arm patient-level meta-analysis for clinical prediction modelling.

  Couillard S, Steyerberg E, Beasley R, Pavord I. Couillard S, et al. BMJ Open. 2022 Apr 1;12(4):e058215. doi: 10.1136/bmjopen-2021-058215. BMJ Open. 2022. PMID: 35365539 Free PMC article.
• Recent Insights into the Management of Inflammation in Asthma.

  Rupani H, Fong WCG, Kyyaly A, Kurukulaaratchy RJ. Rupani H, et al. J Inflamm Res. 2021 Sep 2;14:4371-4397. doi: 10.2147/JIR.S295038. eCollection 2021. J Inflamm Res. 2021. PMID: 34511973 Free PMC article. Review.
• Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma.

  Couillard S, Shrimanker R, Chaudhuri R, Mansur AH, McGarvey LP, Heaney LG, Fowler SJ, Bradding P, Pavord ID, Hinks TSC. Couillard S, et al. Am J Respir Crit Care Med. 2021 Sep 15;204(6):731-734. doi: 10.1164/rccm.202104-1040LE. Am J Respir Crit Care Med. 2021. PMID: 34129808 Free PMC article. No abstract available.
• Treating severe asthma: Targeting the IL-5 pathway.

  Principe S, Porsbjerg C, Bolm Ditlev S, Kjaersgaard Klein D, Golebski K, Dyhre-Petersen N, van Dijk YE, van Bragt JJMH, Dankelman LLH, Dahlen SE, Brightling CE, Vijverberg SJH, Maitland-van der Zee AH. Principe S, et al. Clin Exp Allergy. 2021 Aug;51(8):992-1005. doi: 10.1111/cea.13885. Epub 2021 May 21. Clin Exp Allergy. 2021. PMID: 33887082 Free PMC article. Review.
• Eosinophils as Drivers of Severe Eosinophilic Asthma: Endotypes or Plasticity?

  Van Hulst G, Bureau F, Desmet CJ. Van Hulst G, et al. Int J Mol Sci. 2021 Sep 21;22(18):10150. doi: 10.3390/ijms221810150. Int J Mol Sci. 2021. PMID: 34576313 Free PMC article. Review.